N3Cure

Company Overview

Snapshot

Founded in March 2019 by Sagi Moran, N3Cure operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing its core technology for the plastics industry.

Business overview

N3Cure specializes in developing and manufacturing transformative additive masterbatches for the plastic industry. Its core technology, the CROSSITOL system, combines an additive with a UV energy source to reduce raw material usage by approximately 50%, enhance product performance, and improve manufacturing processes. This system creates a crosslinking reaction, optimizing thermal and mechanical properties, enabling conversion to a single polymer, and achieving desired depth. The UV crosslinking device integrates into existing manufacturing lines, reducing production time, water and energy costs, and carbon footprint. N3Cure operates within the Industrial Technologies sector, focusing on clean manufacturing and sustainable materials for industrial manufacturing, particularly in plastics and packaging.

Company Intelligence Q&A

What is N3Cure's primary focus?

N3Cure focuses on developing and manufacturing transformative additive masterbatches for the plastic industry, aiming to improve product performance and manufacturing efficiency.

What is the CROSSITOL system?

The CROSSITOL system is N3Cure's core technology, comprising an additive and a UV energy source. It facilitates a controlled crosslinking reaction in plastics to optimize thermal and mechanical properties.

What are the environmental benefits of N3Cure's technology?

N3Cure's system reduces raw material usage by approximately 50%, lowers water and energy costs, and decreases the carbon footprint when embedded in manufacturing processes.

When was N3Cure founded?

N3Cure was founded in March 2019.

Who is a key founder of N3Cure?

Sagi Moran is a co-founder and CEO of N3Cure.